Zhang J, Lindroos A, Ollila S, Russell A, Marra G, Mueller H, Peltomaki P, Plasilova M, Heinimann K: Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Res. 2006, 66: 659-664. 10.1158/0008-5472.CAN-05-4043.
Article
CAS
PubMed
Google Scholar
Vasen HF, Mecklin JP, Khan PM, Lynch HT: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991, 34: 424-425. 10.1007/BF02053699.
Article
CAS
PubMed
Google Scholar
Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999, 116: 1453-1456. 10.1016/S0016-5085(99)70510-X.
Article
CAS
PubMed
Google Scholar
Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997, 89: 1758-1762. 10.1093/jnci/89.23.1758.
Article
CAS
PubMed
Google Scholar
Fridrichova I: New aspects in molecular diagnosis of Lynch syndrome (HNPCC). Cancer Biomark. 2006, 2: 37-49.
CAS
PubMed
Google Scholar
Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, de la Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000, 118: 829-834. 10.1016/S0016-5085(00)70168-5.
Article
CAS
PubMed
Google Scholar
Hofstra RM, Spurdle AB, Eccles D, Foulkes WD, de Wind N, Hoogerbrugge N, Hogervorst FB: Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance. Hum Mutat. 2008, 29: 1292-1303. 10.1002/humu.20894.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wijnen J, Klift van der H, Vasen H, Khan PM, Menko F, Tops C, Meijers HH, Lindhout D, Moller P, Fodde R: MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet. 1998, 20: 326-328. 10.1038/3795.
Article
CAS
PubMed
Google Scholar
Gille JJ, Hogervorst FB, Pals G, Wijnen JT, van Schooten RJ, Dommering CJ, Meijer GA, Craanen ME, Nederlof PM, de Jong D, McElgunn CJ, Schouten JP, Menko FH: Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer. 2002, 87: 892-897. 10.1038/sj.bjc.6600565.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wagner A, Barrows A, Wijnen JT, Klift van der H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R: Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet. 2003, 72: 1088-1100. 10.1086/373963.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E: Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer. 2003, 103: 636-641. 10.1002/ijc.10869.
Article
CAS
PubMed
Google Scholar
Grabowski M, Mueller-Koch Y, Grasbon-Frodl E, Koehler U, Keller G, Vogelsang H, Dietmaier W, Kopp R, Siebers U, Schmitt W, Neitzel B, Gruber M, Doerner C, Kerker B, Ruemmele P, Henke G, Holinski-Feder E: Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families. Genet Test. 2005, 9: 138-146. 10.1089/gte.2005.9.138.
Article
CAS
PubMed
Google Scholar
Bunyan DJ, Eccles DM, Sillibourne J, Wilkins E, Thomas NS, Shea-Simonds J, Duncan PJ, Curtis CE, Robinson DO, Harvey JF, Cross NC: Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer. 2004, 91: 1155-1159. 10.1038/sj.bjc.6602121.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baudhuin LM, Ferber MJ, Winters JL, Steenblock KJ, Swanson RL, French AJ, Butz ML, Thibodeau SN: Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. Gastroenterology. 2005, 129: 846-854. 10.1053/j.gastro.2005.06.026.
Article
CAS
PubMed
Google Scholar
Gylling A, Ridanpaa M, Vierimaa O, Aittomaki K, Avela K, Kaariainen H, Laivuori H, Poyhonen M, Sallinen SL, Wallgren-Pettersson C, Jarvinen HJ, Mecklin JP, Peltomaki P: Large genomic rearrangements and germline epimutations in Lynch syndrome. Int J Cancer. 2009, 124: 2333-2340. 10.1002/ijc.24230.
Article
CAS
PubMed
Google Scholar
Kurzawski G, Suchy J, Lener M, Klujszo-Grabowska E, Kladny J, Safranow K, Jakubowska K, Jakubowska A, Huzarski T, Byrski T, Debniak T, Cybulski C, Gronwald J, Oszurek O, Oszutowska D, Kowalska E, Gozdz S, Niepsuj S, Slomski R, Plawski A, Lacka-Wojciechowska A, Rozmiarek A, Fiszer-Maliszewska L, Bebenek M, Sorokin D, Sasiadek MM, Stembalska A, Grzebieniak Z, Kilar E, Stawicka M, Godlewski D, Richter P, Brozek I, Wysocka B, Limon J, Jawien A, Banaszkiewicz Z, Janiszewska H, Kowalczyk J, Czudowska D, Scott RJ, Lubinski J: Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study). Clin Genet. 2006, 69: 40-47. 10.1111/j.1399-0004.2006.00550.x.
Article
CAS
PubMed
Google Scholar
Klift van der H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, Kohonen-Corish M, Vasen H, Oliani C, Barana D, Moller P, Delozier-Blanchet C, Hutter P, Foulkes W, Lynch H, Burn J, Moslein G, Fodde R: Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer. 2005, 44: 123-138. 10.1002/gcc.20219.
Article
PubMed
Google Scholar
Castellvi-Bel S, Castells A, Strunk M, Ferrandez A, Piazuelo E, Mila M, Pinol V, Rodriguez-Moranta F, Andreu M, Lanas A, Pique JM: Genomic rearrangements in MSH2 and MLH1 are rare mutational events in Spanish patients with hereditary nonpolyposis colorectal cancer. Cancer Lett. 2005, 225: 93-98. 10.1016/j.canlet.2005.01.036.
Article
CAS
PubMed
Google Scholar
Martinez-Bouzas C, Ojembarrena E, Beristain E, Errasti J, Viguera N, Tejada Minguez MI: High proportion of large genomic rearrangements in hMSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families of the Basque Country. Cancer Lett. 2007, 255: 295-299. 10.1016/j.canlet.2007.05.004.
Article
CAS
PubMed
Google Scholar
Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, Jarvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B: Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med. 1995, 1: 1203-1206. 10.1038/nm1195-1203.
Article
CAS
PubMed
Google Scholar
Chan TL, Yuen ST, Ho JW, Chan AS, Kwan K, Chung LP, Lam PW, Tse CW, Leung SY: A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing: a founder mutation in the Chinese population. Oncogene. 2001, 20: 2976-2981. 10.1038/sj.onc.1204376.
Article
CAS
PubMed
Google Scholar
Stella A, Surdo NC, Lastella P, Barana D, Oliani C, Tibiletti MG, Viel A, Natale C, Piepoli A, Marra G, Guanti G: Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet. 2007, 71: 130-139. 10.1111/j.1399-0004.2007.00745.x.
Article
CAS
PubMed
Google Scholar
Mauillon JL, Michel P, Limacher JM, Latouche JB, Dechelotte P, Charbonnier F, Martin C, Moreau V, Metayer J, Paillot B, Frebourg T: Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res. 1996, 56: 5728-5733.
CAS
PubMed
Google Scholar
Charbonnier F, Raux G, Wang Q, Drouot N, Cordier F, Limacher JM, Saurin JC, Puisieux A, Olschwang S, Frebourg T: Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res. 2000, 60: 2760-2763.
CAS
PubMed
Google Scholar
Pistorius S, Gorgens H, Plaschke J, Hoehl R, Kruger S, Engel C, Saeger HD, Schackert HK: Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett. 2007, 248: 89-95. 10.1016/j.canlet.2006.06.002.
Article
CAS
PubMed
Google Scholar
Chen JM, Cooper DN, Chuzhanova N, Ferec C, Patrinos GP: Gene conversion: mechanisms, evolution and human disease. Nat Rev Genet. 2007, 8: 762-775. 10.1038/nrg2193.
Article
CAS
PubMed
Google Scholar
Ollikainen M, Hannelius U, Lindgren CM, Abdel-Rahman WM, Kere J, Peltomaki P: Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach. Oncogene. 2007, 26: 4541-4549. 10.1038/sj.onc.1210236.
Article
CAS
PubMed
Google Scholar
Bujalkova M, Zavodna K, Krivulcik T, Ilencikova D, Wolf B, Kovac M, Karner-Hanusch J, Heinimann K, Marra G, Jiricny J, Bartosova Z: Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors. Clin Chem. 2008, 54: 1844-1854. 10.1373/clinchem.2008.108902.
Article
CAS
PubMed
Google Scholar
van Puijenbroek M, Middeldorp A, Tops CM, van Eijk R, Klift van der HM, Vasen HF, Wijnen JT, Hes FJ, Oosting J, van Wezel T, Morreau H: Genome-wide copy neutral LOH is infrequent in familial and sporadic microsatellite unstable carcinomas. Fam Cancer. 2008, 7: 319-330. 10.1007/s10689-008-9194-8.
Article
CAS
PubMed
Google Scholar
Bartosova Z, Fridrichova I, Bujalkova M, Wolf B, Ilencikova D, Krizan P, Hlavcak P, Palaj J, Lukac L, Lukacova M, Boor A, Haider R, Jiricny J, Nystrom-Lahti M, Marra G: Novel MLH1 and MSH2 germline mutations in the first HNPCC families identified in Slovakia. Hum Mutat. 2003, 21: 449-10.1002/humu.9127.
Article
PubMed
Google Scholar
Zavodna K, Bujalkova M, Krivulcik T, Alemayehu A, Skorvaga M, Marra G, Fridrichova I, Jiricny J, Bartosova Z: Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia. Neoplasma. 2006, 53: 269-276.
CAS
PubMed
Google Scholar
Alemayehu A, Tomkova K, Zavodna K, Ventusova K, Krivulcik T, Bujalkova M, Bartosova Z, Fridrichova I: The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis. Neoplasma. 2007, 54: 391-401.
CAS
PubMed
Google Scholar
Truninger K, Menigatti M, Luz J, Russell A, Haider R, Gebbers JO, Bannwart F, Yurtsever H, Neuweiler J, Riehle HM, Cattaruzza MS, Heinimann K, Schar P, Jiricny J, Marra G: Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology. 2005, 128: 1160-1171. 10.1053/j.gastro.2005.01.056.
Article
CAS
PubMed
Google Scholar
Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002, 30: e57-10.1093/nar/gnf056.
Article
PubMed
PubMed Central
Google Scholar
van Dijk MC, Rombout PD, Boots-Sprenger SH, Straatman H, Bernsen MR, Ruiter DJ, Jeuken JW: Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol. 2005, 14: 9-16. 10.1097/01.pas.0000146701.98954.47.
Article
CAS
PubMed
Google Scholar
Tuupanen S, Karhu A, Jarvinen H, Mecklin JP, Launonen V, Aaltonen LA: No evidence for dual role of loss of heterozygosity in hereditary non-polyposis colorectal cancer. Oncogene. 2007, 26: 2513-2517. 10.1038/sj.onc.1210038.
Article
CAS
PubMed
Google Scholar
Dieumegard B, Grandjouan S, Sabourin JC, Le Bihan ML, Lefrere I, Bellefqih , Pignon JP, Rougier P, Lasser P, Benard J, Couturier D, Bressac-de Paillerets B: Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer. 2000, 82: 871-880. 10.1054/bjoc.1999.1014.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alemayehu A, Sebova K, Fridrichova I: Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Genes Chromosomes Cancer. 2008, 47: 906-914. 10.1002/gcc.20586.
Article
CAS
PubMed
Google Scholar
Nakagawa H, Yan H, Lockman J, Hampel H, Kinzler KW, Vogelstein B, de la Chapelle A: Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements. Cancer Res. 2002, 62: 4579-4582.
CAS
PubMed
Google Scholar
Zhu M, Li J, Zhang X, Liu X, Friedl W, Zhang Y, Wu X, Propping P, Wang Y: Large genomic aberrations in MSH2 and MLH1 genes are frequent in Chinese colorectal cancer. Cancer Genet Cytogenet. 2005, 160: 61-67. 10.1016/j.cancergencyto.2004.12.008.
Article
CAS
PubMed
Google Scholar
Di Fiore F, Charbonnier F, Martin C, Frerot S, Olschwang S, Wang Q, Boisson C, Buisine MP, Nilbert M, Lindblom A, Frebourg T: Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet. 2004, 41: 18-20. 10.1136/jmg.2003.012062.
Article
CAS
PubMed
Google Scholar
Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T: MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res. 2002, 62: 848-853.
CAS
PubMed
Google Scholar
Baert-Desurmont S, Buisine MP, Bessenay E, Frerot S, Lovecchio T, Martin C, Olschwang S, Wang Q, Frebourg T: Partial duplications of the MSH2 and MLH1 genes in hereditary nonpolyposis colorectal cancer. Eur J Hum Genet. 2007, 15: 383-386. 10.1038/sj.ejhg.5201765.
Article
CAS
PubMed
Google Scholar
Charbonnier F, Baert-Desurmont S, Liang P, Di Fiore F, Martin C, Frerot S, Olschwang S, Wang Q, Buisine MP, Gilbert B, Nilbert M, Lindblom A, Frebourg T: The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Hum Mutat. 2005, 26: 255-261. 10.1002/humu.20216.
Article
CAS
PubMed
Google Scholar
Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR: Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat. 2003, 22: 428-433. 10.1002/humu.10291.
Article
CAS
PubMed
Google Scholar
Kovacs ME, Papp J, Szentirmay Z, Otto S, Olah E: Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat. 2009, 30: 197-203. 10.1002/humu.20942.
Article
CAS
PubMed
Google Scholar
Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet. 2009, 41: 112-117. 10.1038/ng.283.
Article
CAS
PubMed
Google Scholar
Ruppert JM, Tokino K, Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res. 1993, 53: 5093-5095.
CAS
PubMed
Google Scholar
Yuen ST, Chan TL, Ho JW, Chan AS, Chung LP, Lam PW, Tse CW, Wyllie AH, Leung SY: Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers. Oncogene. 2002, 21: 7585-7592. 10.1038/sj.onc.1205968.
Article
CAS
PubMed
Google Scholar
Hemminki A, Peltomaki P, Mecklin JP, Jarvinen H, Salovaara R, Nystrom-Lahti M, de la Chapelle A, Aaltonen LA: Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet. 1994, 8: 405-410. 10.1038/ng1294-405.
Article
CAS
PubMed
Google Scholar
Lu SL, Akiyama Y, Nagasaki H, Nomizu T, Ikeda E, Baba S, Ushio K, Iwama T, Maruyama K, Yuasa Y: Loss or somatic mutations of hMSH2 occur in hereditary nonpolyposis colorectal cancers with hMSH2 germline mutations. Jpn J Cancer Res. 1996, 87: 279-287.
Article
CAS
PubMed
Google Scholar
Tannergard P, Liu T, Weger A, Nordenskjold M, Lindblom A: Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet. 1997, 101: 51-55. 10.1007/s004390050585.
Article
CAS
PubMed
Google Scholar
Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomaki P: Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol. 2000, 156: 1773-1779.
Article
CAS
PubMed
PubMed Central
Google Scholar
Potocnik U, Glavac D, Golouh R, Ravnik-Glavac M: Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet. 2001, 126: 85-96. 10.1016/S0165-4608(00)00399-X.
Article
CAS
PubMed
Google Scholar
de Abajo S, de la Hoya M, van Puijenbroek M, Godino J, Diaz-Rubio E, Morreau H, Caldes T: Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?. Oncogene. 2006, 25: 2124-2130. 10.1038/sj.onc.1209233.
Article
Google Scholar
Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Onda A, Okumura Y, Kishi N, Iwama T, Mori T, Koike M, Ushio K, Chiba M, Nomizu S, Konishi F, Utsunomiya J, Miyaki M: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology. 1996, 111: 307-317. 10.1053/gast.1996.v111.pm8690195.
Article
CAS
PubMed
Google Scholar